| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
|---|---|
| ISI | infarct size index; initial slope index; injury severity index; Institute for Scientific Information... |
| MCS | malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me... |
| AAC | antibiotic-associated [pseudomembranous] colitis; antimicrobial agent-induced colitis; augmentative ... |
| AAD | acute agitated delirium; alloxazine adenine dinucleotide; alpha-1-antitrypsin deficiency; American A... |
| AAD | Antibiotic associated diarrhea |
|---|---|
| AAC | Antibiotic-associated colitis |
| MAR | Multiple Antibiotic Resistance |
| OPAT | Outpatient parenteral antibiotic therapy |
| PAE | Post Antibiotic Effect |
| antibiotic sensitivity | Microbial susceptibility to antibiotics. See: antibiotic sensitivity test, minimal inhibitory concentration. (05 Mar 2000) |
|---|---|
| antibiotic sensitivity test | The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy. (05 Mar 2000) |
| antibiotic | <pharmacology> A chemical substance produced by a microorganism which has the capacity, in dilute solutions, to inhibit the growth of or to kill other microorganisms. Antibiotics that are sufficiently nontoxic to the host are used as chemotherapeutic agents in the treatment of infectious diseases of man, animals and plants. Origin: Gr. Bios = life (18 Nov 1997) |
|---|---|
| antibiotic assay | <investigation> A test to determine how sensitive a bacterial or fungal strain is to arange of antibiotics bymeasuring the microbes' ability to grow in astandard dilution of each chemical. (09 Oct 1997) |
| antibiotic enterocolitis | Enterocolitis caused by oral administration of broad spectrum antibiotics, resulting from overgrowth of antibiotic-resistant staphylococci or yeasts and fungi, when the normal faecal Gram-negative organisms are suppressed, resulting in diarrhoea or pseudomembranous disease. (05 Mar 2000) |
| antibiotic eye drops | <pharmacology> A medication that is pH balanced to allow placement into the eye for the purpose of killing bacteria. Examples include: Bleph-10, Chloromycetin, Cortisporin-Ophthalmic, Gantrisin, Genoptic, Gentacidin, Garamycin, Gantrisin, Ilotycin, Sodium Sulamyd and Sulphair. (27 Sep 1997) |
| antibiotic induced enteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibiotic induced gastroenteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibiotic ointment | A ointment (or cream) based medication that kills bacteria. Examples include Neosporin, Bactroban, Garamycin, bacitracin, gentamicin, mupirocin, neomycin, silver sulphasalazine, chloramphenicol and clindamycin. (27 Sep 1997) |
| antibiotic prophylaxis | Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications. (12 Dec 1998) |
| antibiotic resistance | The ability of a bacterium tosynthesise a protein that neutralises an antibiotic. (09 Oct 1997) |
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| antibiotic-resistant | Indicating microorganisms that continue to multiply although exposed to antibiotic agents. (05 Mar 2000) |
| broad spectrum antibiotic | An antibiotic having a wide range of activity against both Gram-positive and Gram-negative organisms. (05 Mar 2000) |
| resistance, antibiotic | The ability of bacteria and other microorganisms to withstand an antibiotic to which they were once sensitive (and were once stalled or killed outright). Also called drug resistance. (12 Dec 1998) |
| peptide antibiotic lactonase | <enzyme> Peptide lactone and water gives linear peptide Registry number: EC 3.1.1.- (26 Jun 1999) |
| diarrhoea, antibiotic-induced | A bacterium called Clostridium difficile (C.difficile), one of the most common causes of infection of the large bowel (colon). Patients taking antibiotics are at particular risk of becoming infected with C. Difficile. Antibiotics disrupt the normal bacteria of the bowel, allowing C. Difficile bacteria (and other bacteria) to become established and overgrow the colon. Many persons infected with C. Difficile bacteria have no symptoms but can become carriers of the bacteria and infect others. In other people, a toxin produced by C. Difficile causes diarrhoea, abdominal pain, severe inflammation of the colon (colitis), fever, an elevated white blood count, vomiting and dehydration. In severely affected patients, the inner lining of the colon becomes severely inflamed (a condition called pseudomembranous colitis). Rarely, the walls of the colon wear away and holes develop (colon perforation), which can lead to a life-threatening infection of the abdomen. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|